Skip to main content
aap Implantate AG logo

aap Implantate AG — Investor Relations & Filings

Ticker · AAQ1 ISIN · DE000A3H2101 LEI · 39120001TRQTQ01LPP57 F Manufacturing
Open in API
Filings indexed 854 across all filing types
Latest filing 2021-07-27 Earnings Release
Country DE Germany
Listing F AAQ1

About aap Implantate AG

https://www.aap.de/

aap Implantate AG is a medical technology company that operates as a pure player in the field of traumatology. The company develops, manufactures, and markets implants for the treatment of bone fractures. Its core product is the LOQTEQ® system, a comprehensive portfolio of anatomical plates and screws featuring a patented technology that combines fracture compression with angle-stable locking. This titanium-based system is designed to cover a broad spectrum of indications in upper and lower extremity trauma surgery. In addition to its established product line, aap is developing next-generation platform technologies, including antibacterial silver-coated implants to reduce infection risk and resorbable magnesium implants intended to eliminate the need for secondary removal surgeries.

Recent filings

Filing Released Lang Actions
aap: Significant sales increases in Q2 (+74%) and H1 (+37%) underline growth targets for FY/2021; USA for first time with EUR 1 million sales quarter
Earnings Release Classification · 100% confidence The document text explicitly discusses preliminary sales figures for the second quarter (Q2/2021) and the first half (H1/2021) of the financial year. It highlights key performance indicators (sales growth percentages) and mentions that the final results are planned for announcement on a future date (August 13, 2021). This structure—a press release detailing preliminary period results before the official comprehensive report—is characteristic of an Earnings Release (ER). It is not the full Annual Report (10-K) or the comprehensive Interim Report (IR), but the initial announcement of the results. H1 2021
2021-07-27 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short announcement (1498 characters) titled 'Total Voting Rights Announcement' from aap Implantate AG, dated 30.06.2021. It explicitly states the 'Publication of total number of voting rights' and details a 'Type of capital measure' (Conditional capital increase). This content relates to changes in the company's capital structure and voting rights, but the format is a brief regulatory notification distributed via DGAP (a service for Regulatory Announcements). Since it is a short notification announcing a specific change related to capital/voting rights rather than a comprehensive report, it fits best under Capital/Financing Update (CAP) or potentially a general Regulatory Filing (RNS). Given the specific focus on 'Conditional capital increase' and the resulting 'New total number of voting rights,' CAP is the most precise fit, as it deals directly with capital structure changes, even if presented as a short notice.
2021-06-30 English
Jahres- und Konzernabschluss zum Geschäftsjahr vom 01.01.2020 bis zum 31.12.2020
Report Publication Announcement Classification · 98% confidence The document text is very short (1022 characters) and appears to be a notification or landing page related to a financial report ('Finanzbericht'). It mentions 'Amtliche Offenlegungsdatei' (Official Disclosure File) and discusses the non-official version ('Nichtamtliche Fassung') which includes all report components according to § 325 Abs. 1 HGB (German Commercial Code). Crucially, it provides contact information for obtaining an 'elektronische Beglaubigung' (electronic certification) of the official ESEF format publication, indicating that this document is announcing or providing access to the actual report rather than being the report itself. This aligns perfectly with the definition of a Report Publication Announcement (RPA), which announces the release or availability of a report.
2021-06-25 German
aap Implantate AG: Bekanntmachung der Einberufung zur Hauptversammlung am 15.07.2021 in Berlin mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information Classification · 99% confidence The document is an official announcement ('Bekanntmachung') from aap Implantate AG, dated June 22, 2021, concerning the convening ('Einberufung') of the Annual General Meeting ('Hauptversammlung') scheduled for July 15, 2021. The text explicitly details the agenda items (Tagesordnung), which include the presentation of the annual/consolidated financial statements for 2020, voting on the discharge of the Management Board and Supervisory Board, election of the auditor for 2021, and crucially, a resolution on the approval of the remuneration system for the Management Board members (§ 120a AktG). The core purpose of this filing is to formally invite shareholders to the AGM and present the matters to be voted upon. This aligns perfectly with the definition of materials shared during the Annual General Meeting (AGM-R), as it is the official notice and agenda for that meeting.
2021-06-22 German
Antibacterial silver coating technology: aap's silver coated implant used for first time in patient
Regulatory Filings Classification · 95% confidence The document is a news release dated June 18, 2021, originating from DGAP (a service of EQS Group AG), which typically disseminates corporate news and regulatory announcements. The content details a specific operational milestone: the first use of the company's silver-coated implant in a patient as part of a clinical study. It discusses technology, future regulatory plans (CE approval, FDA pathway), and market potential. This type of announcement, which is not a full financial report (10-K, IR), an earnings release (ER), or a specific shareholder vote result (DVA), fits best into the general category for regulatory news dissemination that doesn't fit a more specific financial or governance code. Since it is a corporate news item distributed via a regulatory service (DGAP) and doesn't fit the definitions for ER, CT, CAP, DIV, etc., the most appropriate fallback is Regulatory Filings (RNS), as it is a general corporate announcement distributed through official channels.
2021-06-18 English
Q1/21: Successful start to the year with sales growth (+9%) and significant earnings improvement (+91%) despite still burdening COVID-19 pandemic - restructuring successes clearly visible
Earnings Release Classification · 100% confidence The document is titled 'Q1/21: Successful start to the year...' and explicitly details financial results for the first quarter (Q1/2021) compared to Q1/2020, including sales figures, EBITDA, and gross margin. It uses keywords like 'Quarter Results' and provides a detailed financial breakdown. This content structure strongly indicates a report summarizing performance for a period shorter than a full year. Therefore, it fits the definition of an Interim / Quarterly Report (IR). It is not a full Annual Report (10-K), nor is it merely an announcement of a report (RPA), as it contains the substantive results. Q1 2021
2021-05-28 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.